Results 241 to 250 of about 468,888 (313)

The Cu\u3csub\u3eA\u3c/sub\u3e Center of a Soluble Domain from \u3cem\u3eThermus\u3c/em\u3e cytochrome ba\u3csub\u3e3\u3c/sub\u3e. An NMR Investigation of the Paramagnetic Protein. A Proton NMR Study of the Paramagnetic Active Site of the Cu\u3csub\u3eA\u3c/sub\u3e Variant of Amicyanin [PDF]

, 1998
Holz, Richard C.
core   +1 more source

Mass Transport Mechanisms in 2D Laminar Nanofluidic Membranes for Separation and Energy Conversion

Carbon Innovation, EarlyView.
This review explores how two‐dimensional laminar membranes govern the transport of ions and molecules in confinement for advanced separation and energy conversion. By discussing how nanochannel architecture shapes membrane performance, this work highlights cation intercalation and functional modifications to improve osmotic energy harvesting ...
Adhy Prihatmiko Wibowo, Xiaojun Ren, Tongxi Lin, Rakesh Joshi   +3 more
wiley   +1 more source

Multilocus sequence typing and genomic characterization of the novel Streptomyces strain SCPE-10, that resists 2,4-D toxicity and has bioremediation potential. [PDF]

Braz J Microbiol
Nhampossa NA, de Almeida Araújo JVC, da Silva VAS, Amaral JRV, da Conceição CS, Gonçalves CAX, Squizani ED, da Silva S, Vidal MS, Chen Y, Macrae A, do Nascimento RP.   +11 more
europepmc   +1 more source

A mitokondriális citokróm c poszttranszlációs érése [PDF]

, 2011
Tenger Katalin
core  

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

Phyllosphere of senescent crops as a microbial N₂O source. [PDF]

Front Microbiol
Tago K, Tokuda SI, Sato Y, Sekiyama Y, Guo Y, Wang Y, Date Y, Hara S, Kuroiwa M, Ohbayashi T, Aoyagi LN, Nishizawa T, Sudo S, Suwa Y, Hayatsu M.   +14 more
europepmc   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5‐HT3 Receptor Antagonists: 2026 Update

Clinical Pharmacology &Therapeutics, EarlyView.
5‐hydroxytryptamine type 3 (5‐HT3) receptor antagonists are used to treat nausea and vomiting and in the prevention of chemotherapy‐induced, radiation‐induced, and postoperative nausea and vomiting. Most of the 5‐HT3 receptor antagonists (i.e., ondansetron, tropisetron, dolasetron, palonosetron, and ramosetron) are metabolized by CYP2D6, but the extent
Claire Moore, Melissa S. Bourque, Andreas Halman, José A. G. Agúndez, Cynthia A. Prows, Keiko Hikino, Matthias Schwab, Carolyn J. Oxencis, Dharmisha Chauhan, Meta H.M. Diekstra, Susie E. Long, Gillian C. Bell, Andrea Gaedigk, Michelle Whirl‐Carrillo, Teri E. Klein, Kelly E. Caudle, Rachel Conyers   +16 more
wiley   +1 more source

Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes. [PDF]

J Diabetes
Li R, Zhang B, Zhang Y, Yang Y, Lu Y, Li J.   +5 more
europepmc   +1 more source

Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism <i>in vitro</i>. [PDF]

PeerJ
Fang P, Ni J, Shen T, Chen Q, Ye X, Jin J, Dai D, Hu G, Qian J, Cai J, Chen L.   +10 more
europepmc   +1 more source

<i>Toxoplasma gondii</i> effector GRA35 mediates neuronal damage <i>via</i> ER stress and mitochondria-associated apoptosis. [PDF]

Virulence
Wang J, Chen Y, Zhou N, Li F, Dai N, Chen Z, Liu S, An R, Chen L, Du J.   +9 more
europepmc   +1 more source